TRAD CHI MED (00570) released its annual performance report, with a net loss of 458 million RMB, compared to a profit in the same period last year.

TRAD CHI MED (00570) announces its annual results ending on December 31, 2025. The group's revenue was RMB 14.745 billion, a decrease of 10.7% year-on-year. It incurred a net loss of RMB 458 million, a turn from profit to loss year-on-year, with a basic loss per share of 6.79 cents. The announcement stated that the loss during the period was mainly due to the increase in the proportion of traditional Chinese medicine formula granules business affected by centralized procurement and intensified market competition, leading to a decrease in revenue and profitability. In addition, there was an increase in impairment of goodwill, impairment of intangible assets, and impairment of credit in this period.